Xponance, Inc. Ionis Pharmaceuticals Inc Transaction History

Xponance, Inc.

$9.68 Billion
Q2 2024

A detailed history of Xponance, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Xponance, Inc. holds 18,115 shares of IONS stock, worth $719,346. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,115

Previous 16,209 11.76%

Holding current value

$719,346

Previous $702,000 22.93%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $69,473 - $90,916	1,906 Added 11.76%	18,115 $863,000
Q1 2024 May 13, 2024	SELL	$42.03 - $53.55 $20,342 - $25,918	-484 Reduced 2.9%	16,209 $702,000
Q4 2023 Jan 31, 2024	SELL	$43.39 - $51.63 $49,594 - $59,013	-1,143 Reduced 6.41%	16,693 $844,000
Q3 2023 Oct 23, 2023	SELL	$38.5 - $47.13 $16,555 - $20,265	-430 Reduced 2.35%	17,836 $809,000
Q2 2023 Jul 13, 2023	BUY	$34.73 - $43.33 $11,773 - $14,688	339 Added 1.89%	18,266 $749,000
Q1 2023 Apr 17, 2023	BUY	$33.58 - $41.2 $7,286 - $8,940	217 Added 1.23%	17,927 $640,000
Q4 2022 Jan 23, 2023	BUY	$37.12 - $46.52 $80,550 - $100,948	2,170 Added 13.96%	17,710 $0
Q3 2022 Oct 24, 2022	BUY	$36.54 - $48.66 $4,457 - $5,936	122 Added 0.79%	15,540 $687,000
Q2 2022 Aug 02, 2022	BUY	$31.71 - $43.0 $16,489 - $22,360	520 Added 3.49%	15,418 $571,000
Q1 2022 Apr 20, 2022	BUY	$29.88 - $37.04 $239 - $296	8 Added 0.05%	14,898 $552,000
Q4 2021 Jan 31, 2022	BUY	$25.61 - $35.1 $8,143 - $11,161	318 Added 2.18%	14,890 $453,000
Q3 2021 Nov 05, 2021	SELL	$33.54 - $40.55 $21,935 - $26,519	-654 Reduced 4.3%	14,572 $489,000
Q2 2021 Aug 12, 2021	BUY	$34.54 - $47.25 $290,930 - $397,986	8,423 Added 123.81%	15,226 $607,000
Q1 2021 May 10, 2021	BUY	$42.51 - $63.78 $977 - $1,466	23 Added 0.34%	6,803 $306,000
Q4 2020 Feb 11, 2021	BUY	$45.3 - $60.27 $9,467 - $12,596	209 Added 3.18%	6,780 $383,000
Q3 2020 Oct 26, 2020	SELL	$47.45 - $62.95 $10,201 - $13,534	-215 Reduced 3.17%	6,571 $312,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $317,924 - $414,285	6,786 New	6,786 $400,000

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account